A study to assess the effect of exenatide treatment on mean 24-hour heart rate in patients with type 2 diabetes
Phase of Trial: Phase III
Latest Information Update: 21 Jul 2014
At a glance
- Drugs Exenatide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- Sponsors AstraZeneca
- 10 Jun 2017 Biomarkers information updated
- 17 Jun 2009 Actual patient number (54) added as reported by ClinicalTrials.gov.
- 23 Jun 2008 Status changed from in progress to completed, reported by ClinicalTrials.gov.